Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07107373
A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US
Sponsor: Bristol-Myers Squibb
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate the real-world safety and effectiveness of patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) initiated on mavacamten at certain high volume HCM centers in the US
Official title: MavAcamten Real World eVidEnce coLlaboration in HCM (MARVEL-HCM)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2023-12-22
Completion Date
2025-12-31
Last Updated
2025-08-06
Healthy Volunteers
No
Interventions
DRUG
Mavacamten
According to the product label
Locations (1)
University of California, San Francisco (UCSF)
San Francisco, California, United States